Eli Lilly & Co. (LLY) Announces US FDA accepts supplemental New Drug Application for Jardiance® for children 10 years and older with type 2 diabetes

Go back to Eli Lilly & Co. (LLY) Announces US FDA accepts supplemental New Drug Application for Jardiance® for children 10 years and older with type 2 diabetes
Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1152.44 --0 (-0%)
Previous Close $1152.44    52 Week High $88.16 
Open $1152.44    52 Week Low $67.88 
Day High $1152.44    P/E 266.77 
Day Low $1152.44    EPS $4.32 
Volume 8,700